News

Vamorolone (VBP15) First-in-patient Studies in Duchenne Muscular Dystrophy Published

Rockville, MD –  2 October 2018
A clinical trial of vamorolone in 48 boys with Duchenne muscular dystrophy entitled “Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug” has been More >